
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Sep 23, 2025 00:08 am UTC| Business Health
Innovent Biologics is gaining momentum in Chinas booming weight-loss drug market with its new therapy Xinermei, launched in July 2025. The once-weekly injectable, also known as mazdutide, joins Novo Nordisks Wegovy and Eli...

Sep 22, 2025 02:42 am UTC| Health Politics Science
The Trump administration is preparing to announce major autism initiatives, according to a report from the Washington Post. Federal health officials are expected to warn pregnant women about the risks of using...

FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Sep 21, 2025 11:50 am UTC| Health Governance Science
The U.S. Food and Drug Administration (FDA) is easing requirements for nicotine pouch manufacturers under a new pilot program, signaling a softer stance on smoking alternatives during the Trump administration....

Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Sep 21, 2025 05:39 am UTC| Politics Health
U.S. President Donald Trump revealed on Saturday that his administration will deliver an important update on autism this Monday, sparking speculation about new health findings. Speaking at a dinner hosted by the...

FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Sep 19, 2025 05:35 am UTC| Health Governance
The U.S. Food and Drug Administration (FDA) is softening its stance on nicotine pouches through a new pilot program, signaling a shift in tobacco regulation under the Trump administration. Traditionally, the FDA required...

CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
Sep 18, 2025 01:24 am UTC| Politics Health Governance
U.S. Health Secretary Robert F. Kennedy Jr. pressured former CDC Director Susan Monarez to approve changes to the childhood vaccination schedule without reviewing scientific evidence, Monarez told a Senate panel Wednesday....

GSK and Eli Lilly Announce Billions in U.S. Manufacturing Investments Amid Tariff Concerns
Sep 17, 2025 02:38 am UTC| Business Health
GlaxoSmithKline (GSK) and Eli Lilly are making major U.S. manufacturing commitments as global pharmaceutical companies expand domestic operations in response to possible tariffs on imported medicines. According to The Wall...